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Conclusions                                                    
• The review revealed evidence of novel cancer risk assessment tools designed for symptomatic individuals in primary care
• There was also evidence on potential benefits and barriers relating to the use of the tools 
• There is a need to address the barriers identified when implementing the tools in general consultations.
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Background
• Cancer risk assessment tools designed to predict cancer risk in symptomatic individuals
in primary care settings are being advocated to address the problem of late diagnosis
of cancer in the UK
• Little is known about the use and implementation of cancer risk assessment tools to aid
early detection of cancer risk in general practice
• We aimed to scope the evidence on the type of cancer risk assessment tools available
for symptomatic individuals, and the current use of the tools including the benefits
and barriers to their use.
Results
• We retrieved a total of 471 papers from the electronic databases and 43 studies matched the inclusion criteria  following a title, abstract and full-text screen by three 
reviewers – one checking where there was disagreement (see flow chart below)
Title & abstract sift of 471 studies 
56 studies full text studies retrieved and sifted 
43 studies selected for the review
415 studies filtered out after title & abstract sift
13 studies excluded after filtering out duplicates 
• Novel cancer risk assessment tools for symptomatic individuals 
in primary care identified from the review included the QCancer
and RAT series 
• While there was some evidence supporting use of some of the 
tools, there was limited evidence on the current use and the 
impact of using the tools on patient outcomes such as rates of 
cancer diagnosis and survival
• There was also some evidence on potential benefits and 
barriers to using the tools in primary care consultations (see 
Table below).
Benefits and barriers to implementing cancer risk assessment tools
Benefits • Potential aid for clinicians to confirm investigations and referral decisions
• Reassurance of patients when investigation not needed
• Helping GPs to recognise symptoms of some cancers
• Useful for detecting cancer risk in patients with complex histories.
Barriers • How to make the tools available to clinicians
• How best to communicate cancer risk information to patients
• Uncertainty about the threshold for action to be taken
• Extra consultation  time requirement
• Potential for causing alarm to patients
• Potential burden on resources
• Challenge about integrating the tools into general practice workflow
• Potential for ‘prompt fatigue.
Methods
• Using Arksey and O’Malley’s framework, we conducted a systematic scoping review of published literature in the English language from 2004 to 2017
• We searched six electronic databases (Medline, CINAHL, Scopus, Cochrane, Science Direct and Psych-INFO) and other sources using specific search terms
e.g Cancer risk assess* tool* AND use or implement* AND symptom* or patient* AND clinician* or general Pract* or primary care or family practice) AND benefit
or impact*
• A narrative synthesis was used to summarise the findings from the studies identified.
